• OPEN AN ACCOUNT
Indian Indices
Nifty
24,273.80 -140.60
(-0.58%)
Sensex
79,665.51 -669.30
( -0.83%)
Bank Nifty
54,365.65 -245.25
( -0.45%)
Nifty IT
36,002.45 82.15
( 0.23%)
Global Indices
Nasdaq
41,380.81 245.84
(0.60%)
Dow Jones
5,684.33 32.05
(0.57%)
Hang Seng
36,949.24 169.58
(0.46%)
Nikkei 225
8,531.61 -27.72
(-0.32%)
Forex
USD-INR
84.70 0.29
(0.35%)
EUR-INR
96.08 0.41
(0.42%)
GBP-INR
112.96 0.38
(0.34%)
JPY-INR
0.59 0.00
(0.19%)

EQUITY - MARKET SCREENER

Sun Pharmaceutical Industries Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524715
INE044A01036
98.3315118
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SUNPHARMA
134.52
423770.54
EPS(TTM)
Face Value()
Div & Yield %
13.13
1
0.76
 

Sun Pharma gains as arm acquires Antibe Therapeutics for $4.5 Million
Mar 18,2025

Sun Pharmaceuticals Industries is a leading global pharmaceutical company with a specialty and generic presence and India's top pharma company.

The pharma major’s consolidated net profit increased 15.04% to Rs 2,903.38 crore on a 10.46% rise in revenue from operations to Rs 13,675.46 crore in Q3 FY25 over Q3 FY24